TSHA - Taysha Gene Therapies, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	Qty	oc	Own	H
8/25/23 16:30	8/24/23	TSHA	Health	BioPrd	Biological Products, (No Diag	Alam Kamran	TX	O	CFO	S	-77	2.33	-33	-11	258	D
7/14/23 16:00	7/12/23	TSHA	Health	BioPrd	Biological Products, (No Diag	Session R.A. II	TX	T		S.m	-61	0.7077	-86	-1	9,154	D
6/26/23 16:46	6/22/23	TSHA	Health	BioPrd	Biological Products, (No Diag	Session R.A. II	TX	T		S.m	-20	0.7033	-29	0	9,240	D
6/22/23 16:00	6/20/23	TSHA	Health	BioPrd	Biological Products, (No Diag	Session R.A. II	TX	T		S.m	-308	0.7083	-435	-4	9,268	D
8/24/22 16:47	8/23/22	TSHA	Health	BioPrd	Biological Products, (No Diag	Alam Kamran	TX	O	CFO	S	-12	3.47	-3	-1	266	D
8/22/22 20:05	8/18/22	TSHA	Health	BioPrd	Biological Products, (No Diag	Alam Kamran	TX	O	CFO	S.m	-106	3.70	-29	-10	269	D
7/7/22 16:30	7/5/22	TSHA	Health	BioPrd	Biological Products, (No Diag	Prasad Suyash	TX	O	CMO,Head	S.m	-48	3.70	-13	-2	531	D
7/1/22 18:55	6/29/22	TSHA	Health	BioPrd	Biological Products, (No Diag	Prasad Suyash	TX	O	CMO,Head	S.m	-183	3.65	-50	-8	543	D
8/20/21 17:52	8/18/21	TSHA	Health	BioPrd	Biological Products, (No Diag	Alam Kamran	TX	O	CFO	S.m	-557	16.88	-33	-10	298	D
7/1/21 18:32	6/29/21	TSHA	Health	BioPrd	Biological Products, (No Diag	Prasad Suyash	TX	O	CMO,Head	S.m	-1,788	22.63	-79	-12	594	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person